• Oncoclínicas said on October 27, 2026, it is not a party to litigation reportedly suspending a mandatory share acquisition offer.
• It had not been notified of the injunction, learning of the case through press reports.
• Valor Econômico reported Centaurus-controlled Josephina III obtained an injunction suspending the CVM-ordered offer, potentially worth R$ 14 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.